VARIAGENICS INC
10-Q, EX-27, 2000-11-14
Previous: VARIAGENICS INC, 10-Q, EX-10.1, 2000-11-14
Next: DOCENT INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      95,357,638
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           102,903,581
<PP&E>                                       6,695,356
<DEPRECIATION>                             (2,007,672)
<TOTAL-ASSETS>                             108,690,365
<CURRENT-LIABILITIES>                        4,553,218
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       231,029
<OTHER-SE>                                 102,825,661
<TOTAL-LIABILITY-AND-EQUITY>               108,690,365
<SALES>                                              0
<TOTAL-REVENUES>                               763,402
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             8,166,477
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              61,482
<INCOME-PRETAX>                            (6,163,563)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (6,163,563)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (6,163,563)
<EPS-BASIC>                                     (0.35)
<EPS-DILUTED>                                   (0.35)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission